Medical News

Comparison of Electrocardiograms (ECG) Waveforms and Central...
Ann Noninvasive Electrocardiol.

The 6-lead hand-held device is potentially useful for a clinical follow-up of remote patients, and for a safety...

22 Jul 2021

Incidence and Predictors of Stent Thrombosis in Patients Tre...
Am J Cardiol.

In conclusion, age, smoking status, chronic kidney disease and a 2-stent strategy were significant predictors of ST...

21 Jul 2021

Risk Factors and Lifestyles in the Development of Atrial Fib...
Am J Cardiol.

In conclusion, high waist circumference, hypertension, cigarette smoking, and poor sleep quality were associated...

20 Jul 2021

Clinical History and Gastrointestinal Bleeding in Patients t...
Int J Cardiol.

The patients' clinical history is neither a predictor for GIB bleeding nor a guide to the choice of the oral...

19 Jul 2021

Key Trials

COMPASS: Rivaroxaban Plus Aspirin reduces the Death Risk vs. Aspirin alone in Patients with Chronic CAD and PAD

This sub-analysis of the COMPASS trial demonstrated that patients with chronic CAD or PAD treated with rivaroxaban-aspirin combination had a reduced...

The Prevalence of Atrial Fibrillation and its Treatment Vary Globally

The prevalence of AF varies widely across the global. Despite the high risk of stroke associated with AF, the use of antithrombotics is less common...

Prolonging DAPT beyond 1 Year may be Effective and Safe in the ESC/EACT Guideline-endorsed High Thrombotic Risk Patients undergoing PCI

According to the findings of the study, prolonging DAPT beyond 1 year in ESC/EACTS guideline-endorsed high thrombotic risk patients, reduced the...

SGLT-2i as Compared with other Antidiabetic Drugs, does not Increase the Risk of Lower Limb Amputation in T2DM Patients

This large-scale study demonstrates no increased risk of lower limb amputation with SGLT-2i other antidiabetic drugs in T2DM patients. T2DM patients...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

 
Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page

Our Publications

Rivazest (Rivaroxaban) Monograph

Rivaroxaban is a potent, selective, orally active direct inhibitor of the activated serine protease Factor X (FXa), which plays a central role in...

Telyse (Tenecteplase) Monograph

In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....

Mexiletine FAQ Booklet

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?

<20%
21% (6 votes)
20-40%
25% (7 votes)
40-50%
14% (4 votes)
50-70%
11% (3 votes)
70-80%
21% (6 votes)
Almost all
7% (2 votes)
Total votes: 28